Cargando…
The optimization method for synthesis of technetium-99m-luteolin as radiotracer in the development of cancer drugs from flavonoid
The aim of this study is to find the optimum conditions of labeling luteolin flavonoid compounds with technetium-99m ((99m)Tc) to meet the purity requirements stated in the United States Pharmacopeia. This compound is expected to be a potential radiotracer compound for diagnosing cancer. The optimiz...
Autores principales: | Ramdhani, Danni, Sriyani, Maula Eka, Nabila, S. Fairuz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305782/ https://www.ncbi.nlm.nih.gov/pubmed/32587817 http://dx.doi.org/10.4103/japtr.JAPTR_161_19 |
Ejemplares similares
-
Technetium-99m-labeled genistein as a potential radical scavenging agent
por: Ramdhani, Danni, et al.
Publicado: (2019) -
Estrogen receptor targeting with genistein radiolabeled Technetium-99(m) as radiotracer of breast cancer: Its optimization, characterization, and predicting stability constants by DFT calculation
por: Ramdhani, Danni, et al.
Publicado: (2023) -
Iodine-131 labeled genistein as a potential radiotracer for breast cancer
por: Ramdhani, Danni, et al.
Publicado: (2020) -
Diagnosis of bone infection by complementary role of technetium-99m MDP and technetium-99m hexamethylpropylene-amineoxime-leukocytes
por: Al-Zahrani, Abdullah, et al.
Publicado: (2012) -
Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes
por: De Silva, Leanne, et al.
Publicado: (2019)